Form 4: Quest Diagnostics Exec Sells Shares for Tax Obligations

Quest Diagnostics SVP Michael J. Deppe sold 88 shares of common stock to cover tax liabilities from restricted share unit vesting.

Summary

• Michael J. Deppe, SVP, Corporate Controller & CAO of Quest Diagnostics Inc. (DGX), reported a transaction involving company common stock.
• On March 2, 2026, Mr. Deppe disposed of 88 shares of common stock at a price of $204.86 per share.
• This sale was conducted to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.
• Following this transaction, Mr. Deppe directly beneficially owns 34,473 shares of common stock, which includes exempt purchases made under the company's stock purchase plan.
• Additionally, Mr. Deppe indirectly beneficially owns 706 shares through the company's tax-qualified Profit Sharing (401(k)) Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation and tax planning, with no significant implications for the company's operational or financial performance.

Negatives

• A minor reduction in direct insider ownership due to the sale of 88 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions, such as sales to cover tax liabilities from RSU vesting, are common across all industries and typically do not reflect a change in management's outlook on the company's performance or future prospects. These are often pre-scheduled events under Rule 10b5-1 plans.

Stakeholder Impact

• Shareholders: Minimal impact due to the small number of shares involved in a routine tax-related sale.

Key Dates

Keywords

Quest Diagnostics, DGX, Insider Trading, Form 4, Stock Sale, Tax Obligations, Restricted Share Units, Michael J. Deppe